Unified clinical trial software
Unified clinical trial software for dermatology trials
oomnia unifies clinical operations for dermatology trials by supporting the evaluation of new and innovative dermatology treatment options and strengthening collaboration between investigators, pharmaceutical partners, and patients
INDUSTRY CONTEXT
Why dermatology trials are hard to run
Dermatology trials are challenging to run because skin‑related conditions vary widely, rely heavily on subjective assessments, and often require specialized imaging, high‑touch patient engagement, and carefully timed recruitment windows
Key challenges include:
Recruitment limitations due to narrow eligibility criteria and competing studies
High patient‑burden and retention issues
Specialized assessments such as imaging, biomarker sampling, and lesion scoring
Seasonal patterns and disease fluctuation
Enrollment barriers linked to low public awareness, limited access, and mistrust
UNIFIED PLATFORM
Why unified clinical trial software matters for dermatology studies
Dermatology trials rely heavily on images, lesion measurements, clinician assessments, patient‑reported outcomes, and longitudinal skin‑change tracking. These data streams are often fragmented across separate systems.
A unified clinical trial platform, built as a Clinical Research Information System (CRIS), brings all dermatology‑specific data into one environment, standardizing image capture, synchronizing assessments, and streamlining endpoint tracking. This improves workflow efficiency, data integrity, and visibility across dermatology trials.
| Area | Modular eClinical system | Unified clinical trial software |
|---|---|---|
| Data types | Images, lesion measurements, investigator assessments, and ePRO data captured in separate tools | All dermatology data, images, scores, measurements, and PROs, captured and stored in one environment |
| Consistency & scoring | Variability in image quality, lighting, and scoring across sites; inconsistent lesion documentation | Standardized imaging workflows and scoring criteria applied consistently across all visits and locations |
| Image–assessment alignment | Images stored in one system while clinical assessments live in another, requiring cross‑referencing | Automatic linkage between images, visit data, and investigator assessments within a shared record |
| Patient monitoring | Delayed visibility into lesion progression; manual comparison of photos and scores | Continuous, real‑time tracking of skin‑related endpoints with side‑by‑side historical imaging |
| Study workflow execution | Multiple logins, incompatible tools, and redundant data entry across imaging, eCOA/ePRO, and CRFs | Streamlined workflows connecting sites, CRAs, and central reviewers in one platform |
| Data quality | Higher risk of inconsistent imaging, missing assessments, and incomplete documentation | Structured dermatology‑specific data capture with built‑in quality checks and required fields |
CRIS ARCHITECTURE
One unified clinical trial platform for dermatology trials
oomnia brings all core dermatology trial operations into one unified clinical research information system (CRIS), helping teams manage complex, multi-endpoint studies with greater speed and consistency
Built for dermatology's multi-endpoint data needs, with a strong focus on complex scoring instruments and photodocumentation workflows
Single data model keeps clinical, operational, and PRO data aligned, reducing cross-site variability and creating a stable structure for high-volume skin disease data streams
Protocol updates handled through configuration, enabling adjustments without system rebuilds
Replaces fragmented tools with one connected workflow, cutting handoffs and minimizing reconciliation
ECOSYSTEM INTEGRATION
How oomnia fits in the dermatology sponsor ecosystem
oomnia serves as the central clinical data hub connecting all stakeholders across dermatology trial programs, ensuring consistent data flow and smooth coordination throughout the study
It integrates:
KEY CAPABILITIES
Key capabilities for dermatology trials
Flexible study design for variable skin conditions
- Handles complex dermatology protocols that rely on frequent assessments, lesion scoring, imaging, and flare‑dependent visit schedules
- Easily adapts when inclusion criteria shift, assessment timing changes, or new cohorts are added
- Keeps studies stable during mid‑trial updates, even when disease variability requires rapid protocol adjustments
Consistent clinical and imaging data
- Captures clinical observations, imaging results, and symptom‑based ePRO data in real time
- Unifies all core tools, EDC, CTMS, RTSM, ePRO/eCOA, eTMF, eSource, and eConsent, into a single dermatology‑focused workflow
- Reduces manual reconciliation caused by scattered systems, supporting cleaner, more consistent dermatology data
Patient engagement and retention
- Provides flexible ePRO/eCOA tools for itch severity, pain, flare frequency, Quality of Life (QoL) impact, and treatment adherence
- Supports both remote and in‑clinic reporting, making it easier for patients to stay engaged despite burdensome visit schedules
- Uses automated reminders to reduce missed assessments, critical in studies with high dropout risk
Real-time study progress monitoring
- Offers real‑time dashboards combining clinical data, skin‑imaging outputs, laboratory results, and patient‑reported symptoms
- Supports interim reviews, safety checks, and evidence‑based decisions across geographically dispersed dermatology studies
- Generates export‑ready files that simplify submission packages for global dermatology regulatory pathways
Imaging and dermatopathology data together
- Integrates high‑resolution lesion photography, digital image grading, and central imaging reads directly into the unified platform
- Connects dermatopathology and biomarker data with safety and efficacy monitoring
- Provides a consolidated view of clinical outcomes, imaging trends, disease‑activity changes, and objective/subjective endpoints
Purpose‑built to support the unique demands of dermatology research
Operates on one unified clinical architecture instead of stitched‑together systems
Adapts quickly when protocols change
Reduces operational friction for sites, sponsors, and CROs
Eliminates the need to manage multiple disconnected dermatology tools
VALUE PROPOSITION
Why sponsors choose oomnia for dermatology trials
Client Testimonials
Collaboration built on trust and innovation
Wemedoo's technology, expertise, and intimate engagement with our team in the development of the EDC, site/patient interface, and metric capabilities are unique. They provided insight and challenged the underlying assumptions to ensure the study's goals and objectives were clearly defined and the operating structure matched with the study's intent. Their system is not a one-size-fits-all and they adapt to the needs of the sponsor, sites, physicians, and the study requirements into a system that merges health information/data and can then become not only informative but actionable.
James Kuras
Vice President of Clinical Affairs and Operations at Centinel Spine
Wemedoo's cross-functional, integrated teams capture EDC set-up, go-live, data capture, data cleaning, and finally data analysis in a globally compliant fashion supporting trials in different geographies including the US. Their speed of addressing customer needs sets in my personal experience industry benchmark whilst keeping these data solutions lean and affordable. Besides the great proprietary systems they use, their integrated team approach with personal responsibility and honest commitment to targeting outcomes differentiates the Wemedoo team from other providers. Wemedoo only made Oxular's key initial trial, a device-drug trial possible, as based on some pre-work, the Wemedoo team could substantially adapt and update the first EDC ideas for a trial under a US FDA IND. The Wemedoo team worked extremely focused on familiarizing US trial sites and clinical CROs with the use of their system, which turned out to be a key success factor of the respective trial. The highly professional and up-to-date capabilities in data sciences were mirrored by customer-centricity and super fast timelines of integrating mandatory adaptations to the data systems.
Friedrich Asmus
Former Chief Medical Officer at OXULAR
All jobs, both large and small, are performed with the same dedication to quality, detail, innovative thinking, and rigor. It is always a pleasure to work with the Wemedoo team.
Georg Mathis, PhD
CEO at Appletree CI Group AG
Wemedoo embodies all the traits desired in a partner in the clinical trial industry – expertise, innovation, reliability, compliance, and attention to detail.
Martina Diminic Smetisko, DMD
Managing Director at Marti Farm Ltd
Their dedication to, and support of, our projects has resulted in clear quality deliverables. They are always there to answer any questions with expertise in a timely manner. I am looking forward to our next project together.
Volodymyr Stus, MD
Biopharmaceutics and Clinical Research Department Manager at Polpharma SA
Complex adaptive trials demand speed, precision, and system stability. With oomnia, Wemedoo's unified clinical trial software maintained continuous drug supply oversight, real-time data capture above 99%, and zero Randomization and Trial Supply Management (RTSM) dispensing errors throughout the study. The study reached database lock within 3 days after Last Patient Last Visit (LPLV), a direct result of integrated EDC–RTSM execution and proactive technical support. Wemedoo's technology and team responsiveness played a key role in meeting aggressive milestones.
Dhiraj Patel, Dr.
Director at Velocious Clinical Research
REGULATORY READINESS
Regulatory and data ecosystem readiness
oomnia delivers a structured, compliance‑ready environment tailored to the regulatory and data demands of dermatology trials
21 CFR Part 11 compliance
21 CFR Part 11–ready records with full audit trails and secure electronic signatures
Risk-Based Quality Management
Risk‑Based Quality Management aligned with ICH E6(R3) built directly into everyday workflows
CDISC-aligned data standards
CDISC‑aligned dermatology data formats, including standardized collection structures and SDTM‑compatible outputs
Global regulatory support
Submission‑ready documentation for FDA, EMA, and other global authorities
Get Started
Bring all your dermatology trial data together
See how oomnia centralizes imaging workflows, flare‑based assessments, and symptom tracking to make execution far more manageable
Talk to our team